glutathione for non alcoholic fatty liver and Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) sub q glutathione Current treatment

In this paper, we discussed the extra-erythrocytic functions of L-glutamine in SCD

Tirzepatide is a synthetic peptide consisting of 39 amino acids, based on the GIP sequence but modified to also activate the GLP-1 receptor

GHK-Cus favorable 40+ year safety profile with research compound status suits those comfortable with emerging treatments backed by strong mechanistic rationale

Reports of short-term tolerance exist in small observational settings, yet these reports lack randomized control, large populations, and multi-year follow-up

Compounding medications in a rural setting: an interprofessional perspective